Concomitant Drug Interactions With Non–Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation
For patients with nonvalvular atrial fibrillation taking non-vitamin K oral anticoagulants, several concurrent medications were associated with increased risks of intracranial hemorrhage, major bleeding hospitalizations, and overall mortality.
Authors
- Yap‐Hang Chan (ORCID: https://orcid.org/0000-0001-5384-8468)
- Kui Kai Lau (ORCID: https://orcid.org/0000-0002-8657-2418)
- Jo Jo Hai (ORCID: https://orcid.org/0000-0002-2276-5966)
- Gregory Y.H. Lip (ORCID: https://orcid.org/0000-0002-7566-1626)
- Chun‐Ka Wong (ORCID: https://orcid.org/0000-0001-5205-9440)
- Hung‐Fat Tse (ORCID: https://orcid.org/0000-0002-9578-7808)
- Mei-Yi Lin (ORCID: https://orcid.org/0000-0002-7168-7976)
- Yuen‐Kwun Wong (ORCID: https://orcid.org/0000-0001-6946-344X)
- Kai‐Hang Yiu
Institutions
- University of Liverpool (GB)
- Guangzhou Institutes of Biomedicine and Health (CN)
- Liverpool Heart and Chest Hospital (GB)
- Center for Translational Molecular Medicine (NL)
- University of Hong Kong - Shenzhen Hospital (CN)
- University of Hong Kong (HK)
- Aalborg University (DK)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1161/jaha.124.038668
- Citations
- 5
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 6.94